MARKET IS OPEN
Loading latest tickers...
Market Indices
S&P 500
$7,818.93
+0.58%
NASDAQ 100
$31,224.47
+0.48%
DOW JONES
$51,521.00
+0.49%
NASDAQ Composite
$27,599.79
+0.45%
RUSSELL 2000
$2,813.40
-0.72%
CBOE VIX
$15.01
-3.29%
Sector Heatmap
Technology+0.53%
Financials+0.24%
Healthcare-0.17%
Consumer Cycl+1.20%
Consumer Staples+0.90%
Energy+0.47%
Industrials+0.87%
Materials+0.46%
Real Estate+1.06%
Utilities+2.98%
Comm Services+0.04%
NXTS — Nexentis Technologies Inc. Common Stock
NasdaqNexentis Technologies Inc. Common Stock
$1.39
+0.01(+0.72%)
- O
- 1.39
- H
- 1.41
- L
- 1.38
- V
- 3.15K
⏱️ End-of-day dataAs of Oct 6, 2026
Chart
About NXTS
Nexentis Technologies Inc, is engaged in redefining mitochondrial drug discovery with help of its wholly owned biotechnology subsidiary, MitoCareX Bio focused on drug discovery company dedicated to developing first-in-class therapeutics for inflammatory metabolic diseases and cancer by targeting specific metabolic pathways. The company is also focused on sustainable operations in various industries such as solar projects, and oncology biotechnology.
IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateDec 15, 2009
Employees9
Stock ExchangeNasdaq
Ticker SymbolNXTS
Websitehttps://nexentistech.com
Key Financial Statistics
| Market Cap | $2.17M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $1.14 - $49.00 |
| 52-Week Avg Volume | 375.2K |
| VWAP | $1.38 |
| Transactions | 118 |
| Total Recorded Bars | 3,997 days |